◂ Announcements

Oct 7, 2025ACQUISITIONUnited States

DEKA Research & Development acquires assets from Diatech Diabetes

DEKA Research & Development acquired core assets and intellectual property from Diatech Diabetes, including the SmartFusion infusion monitoring software. The deal also includes the hiring of select leadership from Diatech.

Status

Completed

ProductsSmartFusion infusion monitoring softwareinsulin pump technology

CompaniesDEKA Research & Development acquirer Diatech Diabetes target

Sectors#Medical Devices

“We are excited to bring Diatech's technology and team into DEKA.”drugdeliverybusiness.com

1 source
drugdeliverybusiness.comSequel twiist maker DEKA acquires assets from Diatech DiabetesSean WhooleyOct 7, 2025

Summarized from public sources; check the original articles before acting on it.

Similar announcements

Nov 6, 2026ACQUISITIONUnited States$9.90B
Danaher to acquire Masimo for $9.9 billion
Danaher acquirer Masimo target mdtvnow.com
Nov 5, 2026ACQUISITIONUnited States
Curewell Capital to acquire majority stake in ECA Medical
Curewell Capital acquirer ECA Medical target businesswire.com
Nov 5, 2026ACQUISITIONUnited States$538.0M
ZOLL Medical to acquire Itamar Medical for $538M
Asahi Kasei investor ZOLL Medical Corporation acquirer forpressrelease.com
Nov 4, 2026ACQUISITIONPlano, Texas, United States$2.25M
OSTEONIC acquires controlling stake in FoxEyes for 3 billion won
OSTEONIC FoxEyes target en.edaily.co.kr
Nov 3, 2026ACQUISITIONDeerfield, Illinois, United States
Vantive to divest majority of hemodialysis assets to Rockwell Medical
Vantive Rockwell Medical acquirer prnewswire.com
Nov 2, 2026ACQUISITIONUnited States$40.0M
Ingersoll Rand acquires precision-pump maker IVEK Corporation
Ingersoll Rand acquirer IVEK Corporation target dealroom.co pumpindustry.com worldpumps.com

Loading…